EXPANDED ACCESS FOR Lu-PSMA-617 - Advanced Prostate...

Advanced Prostate Cancer

20,997 members26,168 posts

EXPANDED ACCESS FOR Lu-PSMA-617

skateguy profile image
14 Replies

Expanded access allows a patient with metastatic castration-resistant prostate cancer access to an investigative medical product prior to its commercial availability. This is not a trial. The disclosure states that I will be provided with information defining which procedures, tests, or drugs that I will be responsible. My PSMA scan is scheduled for 24 November and my first injection should be the first or second week on December. This is available at Johns Hopkins in Baltimore, MD if anyone is interested. I was the second person to sign up. More information at hopkinsmedicine.org/kimmel_...

Written by
skateguy profile image
skateguy
To view profiles and participate in discussions please or .
Read more about...
14 Replies

Great post, thanks for getting this out!

Javelin18 profile image
Javelin18

That’s great that you are getting treated so quickly. I had a PSMA scan on October 15, and got accepted to the access program at UCLA. My first treatment wasn’t going to be until January 13, but an opening on the schedule came up last week. With more sites opening, the wait times should go down for everyone

Bkraus1 profile image
Bkraus1

Since this isn’t a trial, what is the estimated cost of the injection?

skateguy profile image
skateguy in reply to Bkraus1

I do not know at this time, but I would guess it would be the same as when it is commercially available with the exception of scans that the OEM wants to determine effectiveness. But, we will have to wait and see.

Javelin18 profile image
Javelin18 in reply to skateguy

With the expanded access program at UCLA, there is no cost for the drug. I believe this is true everywhere.

There are $1300 in treatment related costs that I think are covered by insurance. I had to pay out of pocket on my first treatment. I was taking advantage of an opening in the waiting list, and then hadn’t received preapproval yet

fmenninger profile image
fmenninger

What is the cost?

skateguy profile image
skateguy in reply to fmenninger

See my response to the comment above.

monte1111 profile image
monte1111

No jokes. This sounds great if you can pull it off.

skateguy profile image
skateguy in reply to monte1111

My PSA has been as high as 4200. I'm told that people with high PSA readings have high PSMA levels. The scan will hopefully show that, because after living with stage 4 PC for 11 years, I'm running out of options.

Spyder54 profile image
Spyder54

Much appreciated. Way to share!Mike

djm21m profile image
djm21m

Congratulations. Sounds like you are moving through the process quickly. Who is your Doctor at Hopkins ?

skateguy profile image
skateguy in reply to djm21m

Dr Denmeade is my oncologist. But I will admit I see another one at a different facility. Dr Martin Pompey is the lead for this treatment.

swwags profile image
swwags

What is your status skateguy? Any updates for us please?

skateguy profile image
skateguy

I was negative for PSMA. So I looked into trial’s. I was scheduled to get evaluated for a CAR-T trial at Columbia in Manhattan about two weeks ago. Prior to going in, cancer in my spine effected my nerves and basically confined me to a wheelchair. I was told that Hospice was the next step. However, I found one Dr who thinks he may help me. Arriving the Mayo Clinic tomorrow to be evaluated to see if they can reverse this hasty disease. Have fun and good luck.

You may also like...

Opinions on Lu-PSMA-617 Clinical Trial

trials or chemotherapy now for his metastatic castration resistant prostate cancer (metastasized to...

Sites for Lu PSMA Early Access Program

news today. Got my PSMA scan Friday, which showed intermediate to high PSMA expression. Got MRI...

Lu-177-PSMA-617 update- (4 weeks after 1st treatment)

could be from the combination of Lupron, lu-177-PSMA, and Xgeva. It’s pretty severe this time, he...

UCLA is expanding access to the Ga-68-PSMA-11 PET scan

They have announced expanded access to the PET scan until the FDA approves it, hopefully by this...

VISION trial results of Lu-177-PSMA-617

(rPFS) in patients with PSMA-positive metastatic castration-resistant prostate cancer. Details...